Interaction ID
ncRI-40671977
Interaction Molecules
hsa-miR-106a-3p -- VANGL1
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
TargetScan with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T;HEK293S
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by TargetScan and miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000173218
Description
mRNA
Pubmed ID | 23824327 | Journal | Genes & development |
---|---|---|---|
Title | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. | ||
Author | Karginov FV, Hannon GJ |
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-106a-3p | acute myeloid leukemia | MNDR Database |
hsa-miR-106a-3p | acute T cell leukemia | MNDR Database |
hsa-miR-106a-3p | adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | adenoma | MNDR Database |
hsa-miR-106a-3p | Alzheimer's disease | MNDR Database |
hsa-miR-106a-3p | amyotrophic lateral sclerosis | MNDR Database |
hsa-miR-106a-3p | aortic valve disease | MNDR Database |
hsa-miR-106a-3p | Arsenic Poisoning | MNDR Database |
hsa-miR-106a-3p | astrocytoma | MNDR Database |
hsa-miR-106a-3p | autism spectrum disorder | MNDR Database |
hsa-miR-106a-3p | autosomal recessive limb-girdle muscular dystrophy type 2A | MNDR Database |
hsa-miR-106a-3p | autosomal recessive limb-girdle muscular dystrophy type 2B | MNDR Database |
hsa-miR-106a-3p | B-cell lymphoma | MNDR Database |
hsa-miR-106a-3p | biliary tract cancer | MNDR Database |
hsa-miR-106a-3p | bladder urothelial carcinoma | MNDR Database |
hsa-miR-106a-3p | bone disease | MNDR Database |
hsa-miR-106a-3p | brain disease | MNDR Database |
hsa-miR-106a-3p | breast cancer | MNDR Database |
hsa-miR-106a-3p | Breast Neoplasms | MNDR Database |
hsa-miR-106a-3p | Burkitt lymphoma | MNDR Database |
hsa-miR-106a-3p | cancer | MNDR Database |
hsa-miR-106a-3p | carcinoma | MNDR Database |
hsa-miR-106a-3p | Carcinoma, Ductal, Breast | MNDR Database |
hsa-miR-106a-3p | Carcinoma, Non-Small-Cell Lung | MNDR Database |
hsa-miR-106a-3p | Carcinoma, Renal Cell | MNDR Database |
hsa-miR-106a-3p | cervical adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | cervical squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | cholangiocarcinoma | MNDR Database |
hsa-miR-106a-3p | chronic fatigue syndrome | MNDR Database |
hsa-miR-106a-3p | chronic lymphocytic leukemia | MNDR Database |
hsa-miR-106a-3p | chronic myeloid leukemia | MNDR Database |
hsa-miR-106a-3p | colon adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | colon cancer | MNDR Database |
hsa-miR-106a-3p | colorectal cancer | MNDR Database |
hsa-miR-106a-3p | Crohn's disease | MNDR Database |
hsa-miR-106a-3p | diabetes mellitus | MNDR Database |
hsa-miR-106a-3p | diffuse large B-cell lymphoma | MNDR Database |
hsa-miR-106a-3p | dilated cardiomyopathy | MNDR Database |
hsa-miR-106a-3p | Down syndrome | MNDR Database |
hsa-miR-106a-3p | Duke C | MNDR Database |
hsa-miR-106a-3p | embryonal cancer | MNDR Database |
hsa-miR-106a-3p | endometrial cancer | MNDR Database |
hsa-miR-106a-3p | Ependymoma | MNDR Database |
hsa-miR-106a-3p | esophageal cancer | MNDR Database |
hsa-miR-106a-3p | eye disease | MNDR Database |
hsa-miR-106a-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-106a-3p | Fatty Liver | MNDR Database |
hsa-miR-106a-3p | follicular lymphoma | MNDR Database |
hsa-miR-106a-3p | fragile X syndrome | MNDR Database |
hsa-miR-106a-3p | gastric adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | gastric lymphoma | MNDR Database |
hsa-miR-106a-3p | Glioblastoma | MNDR Database |
hsa-miR-106a-3p | head and neck cancer | MNDR Database |
hsa-miR-106a-3p | head and neck squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | Heart Failure | MNDR Database |
hsa-miR-106a-3p | hepatitis B | MNDR Database |
hsa-miR-106a-3p | Hepatitis, Viral, Human | MNDR Database |
hsa-miR-106a-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-106a-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-106a-3p | Hodgkin's lymphoma | MNDR Database |
hsa-miR-106a-3p | Huntington's disease | MNDR Database |
hsa-miR-106a-3p | hypersensitivity reaction type II disease | MNDR Database |
hsa-miR-106a-3p | Hypersomnolence, Idiopathic | MNDR Database |
hsa-miR-106a-3p | inflammatory bowel disease | MNDR Database |
hsa-miR-106a-3p | intellectual disability | MNDR Database |
hsa-miR-106a-3p | kidney cancer | MNDR Database |
hsa-miR-106a-3p | Lesch-Nyhan syndrome | MNDR Database |
hsa-miR-106a-3p | leukemia | MNDR Database |
hsa-miR-106a-3p | Lewy body dementia | MNDR Database |
hsa-miR-106a-3p | liposarcoma | MNDR Database |
hsa-miR-106a-3p | Liver Neoplasms | MNDR Database |
hsa-miR-106a-3p | lung adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | lung cancer | MNDR Database |
hsa-miR-106a-3p | lung small cell carcinoma | MNDR Database |
hsa-miR-106a-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | Lymphoblastoid | MNDR Database |
hsa-miR-106a-3p | lymphoma | MNDR Database |
hsa-miR-106a-3p | Lymphoma, Follicular | MNDR Database |
hsa-miR-106a-3p | Lymphoma, Non-Hodgkin | MNDR Database |
hsa-miR-106a-3p | malignant glioma | MNDR Database |
hsa-miR-106a-3p | medulloblastoma | MNDR Database |
hsa-miR-106a-3p | melanoma | MNDR Database |
hsa-miR-106a-3p | meningioma | MNDR Database |
hsa-miR-106a-3p | Mesothelioma | MNDR Database |
hsa-miR-106a-3p | multiple myeloma | MNDR Database |
hsa-miR-106a-3p | multiple sclerosis | MNDR Database |
hsa-miR-106a-3p | Multiple Sclerosis, Chronic Progressive | MNDR Database |
hsa-miR-106a-3p | muscular disease | MNDR Database |
hsa-miR-106a-3p | myelodysplastic/myeloproliferative neoplasm | MNDR Database |
hsa-miR-106a-3p | nasopharynx carcinoma | MNDR Database |
hsa-miR-106a-3p | nemaline myopathy | MNDR Database |
hsa-miR-106a-3p | Neoplasms | MNDR Database |
hsa-miR-106a-3p | nephroblastoma | MNDR Database |
hsa-miR-106a-3p | neuroblastoma | MNDR Database |
hsa-miR-106a-3p | neurodegenerative disease | MNDR Database |
hsa-miR-106a-3p | oral squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | osteosarcoma | MNDR Database |
hsa-miR-106a-3p | ovarian carcinoma | MNDR Database |
hsa-miR-106a-3p | ovarian clear cell carcinoma | MNDR Database |
hsa-miR-106a-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-106a-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | pancreatic cancer | MNDR Database |
hsa-miR-106a-3p | papillary renal cell carcinoma | MNDR Database |
hsa-miR-106a-3p | papillary thyroid carcinoma | MNDR Database |
hsa-miR-106a-3p | Parkinson's disease | MNDR Database |
hsa-miR-106a-3p | Precursor Cell Lymphoblastic Leukemia-Lymphoma | MNDR Database |
hsa-miR-106a-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-106a-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-106a-3p | prostate adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | Prostatic Neoplasms | MNDR Database |
hsa-miR-106a-3p | Pseudorabies | MNDR Database |
hsa-miR-106a-3p | psoriasis | MNDR Database |
hsa-miR-106a-3p | rectum adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | relapsing-remitting multiple sclerosis | MNDR Database |
hsa-miR-106a-3p | renal cell carcinoma | MNDR Database |
hsa-miR-106a-3p | renal clear cell carcinoma | MNDR Database |
hsa-miR-106a-3p | Retinal Neovascularization | MNDR Database |
hsa-miR-106a-3p | rhabdomyosarcoma | MNDR Database |
hsa-miR-106a-3p | Sepsis | MNDR Database |
hsa-miR-106a-3p | small intestine cancer | MNDR Database |
hsa-miR-106a-3p | squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | stomach cancer | MNDR Database |
hsa-miR-106a-3p | Stroke, Lacunar | MNDR Database |
hsa-miR-106a-3p | syndrome | MNDR Database |
hsa-miR-106a-3p | T-cell leukemia | MNDR Database |
hsa-miR-106a-3p | temporal lobe epilepsy | MNDR Database |
hsa-miR-106a-3p | testicular germ cell cancer | MNDR Database |
hsa-miR-106a-3p | thyroid cancer | MNDR Database |
hsa-miR-106a-3p | thyroid carcinoma | MNDR Database |
hsa-miR-106a-3p | Toxoplasma | MNDR Database |
hsa-miR-106a-3p | toxoplasmosis | MNDR Database |
hsa-miR-106a-3p | Urinary Bladder Neoplasms | MNDR Database |
hsa-miR-106a-3p | uterine corpus endometrial carcinoma | MNDR Database |
hsa-miR-106a-3p | Uterine Cervical Neoplasms | MNDR Database |
hsa-miR-106a-3p | vascular disease | MNDR Database |
hsa-miR-106a-3p | neural tube defects, susceptibility to | eDGAR Database |
hsa-miR-106a-3p | sacral defect with anterior meningocele | eDGAR Database |